Home > Clinical Trials

Saved trials

Not yet recruiting
NCT05953168
T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients
69 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Triple-Negative Breast Cancer
Completed
NCT03456102
Statin Adjunctive Therapy for TB
16 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Tuberculosis
Recruiting
NCT05919212
Trastuzumab Deruxtecan (T-DXd): Tailoring Treatment and Companion Diagnostics (CDx) by Liquid Biopsy
22 Enrollment(s)
1 Study location(s)
Interventional (Not Applicable)
Metastatic Breast Cancer
Not yet recruiting
NCT05917275
Multi-Omics to Predict the Blood Pressure Response to Antihypertensives
96 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Primary Hypertension
Completed
NCT04752059
Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases
15 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Breast Cancer Stage IV
Recruiting
NCT05458401
EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan
200 Enrollment(s)
21 Study location(s)
Observational
HER2-positive Breast Cancer
Not yet recruiting
NCT05852769
A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants
18 Enrollment(s)
0 Study location(s)
Interventional (Phase I)
Healthy Volunteers
Completed
NCT05223335
Clopidogrel Monotherapy in Patients With High Bleeding Risk
121 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Bleeding Complications